Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Locally Advanced Pancreatic Cancer After Systemic Therapy: Ablative MR-guided Radiotherapy, a Randomized Controlled Trial

NCT06272162 is registered in ClinicalTrials.gov with UMC Utrecht as lead sponsor.

NCT NCT06272162
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06272162 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Locally Advanced Pancreatic Cancer After Systemic Therapy: Ablative MR-guided Radiotherapy, a Randomized Controlled Trial
Lead sponsor
UMC Utrecht
Phase
Not applicable
Overall status
Not yet recruiting
Start date
February 29, 2024
Completion date
January 31, 2030
Enrollment
150 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

locally advanced pancreatic adenocarcinoma